Gilmore Oneill News Today : Breaking News, Live Updates & Top Stories | Vimarsana

How Editas dragged new CSO over after 37 years at Biogen

How Editas dragged new CSO over after 37 years at Biogen
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United statesLinda burklyGilmore oneillAmerican society of geneAmerican societyCell therapyVertex pharmaceuticalEdita cas

Editas Medicine, Inc (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript

Editas Medicine, Inc (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesBrian chengMary kateErick luceraSamantha semenkowCristi barnettLinda burklyBristol myers squibbGreg whiteheadGilmore oneillMani forooharJack allenJoon leeEmmanuelle charpentierCaren deardorfBaisong mei

Editas Medicine Announces First Quarter 2024 Results and Business Updates

Editas Medicine Announces First Quarter 2024 Results and Business Updates
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkUnited kingdomCristi barnettGregory whiteheadVivo hemoglobinopathiesEmmanuelle charpentierBristol myers squibbGilmore oneillLas vegasEditas medicine incBroad institute casUniversity of viennaVertex pharmaceuticals incorporatedGenetic medicines forumHarvard university cas

Editas Medicine, Inc (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript

Editas Medicine, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.52.

United statesGreg harrisonLinda burklyGilmore oneillBaisong meiCaren deardorfBrian chengErick luceraJoon leeCristi barnettSamantha semenkowCorporate communicationsEditas medicine incVertex pharmaceuticalsEditas medicineCall transcript february

Editas Medicine, Inc (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript

Editas Medicine, Inc. (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript February 28, 2024 Editas Medicine, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.52. EDIT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to Editas […]

Baisong meiGilmore oneillErick luceraJoon leeMost valuable electric car companiesChief financialValuable electric car companies